Step 3 Activate GLP-1 Pathways and Support Satiety: HOWARU Shape B420 and Akkermansia muciniphila are described as clinically studied strains positioned around supporting natural GLP-1 production and healthy body composition markers
The primary outcome of this study was the first diagnosis of CRC within 15 years from the initial treatment of GLP-1RAs or non-GLP-1RA diabetes medications (insulin, metformin, alpha-glucosidase inhibitors, dipeptidyl-peptidase-4 inhibitors (DPP-4i), sodium-glucose cotransporter-2 inhibitors (SGLT2i), sulfonylureas (SU), and thiazolidinediones (TZD))
After 4 weeks, increase to 1mL (10 mg daily which is the final recommended dose
Lara Spencer has the details
Sold for in-vitro laboratory research only
Effect on cell surface hydrophobicity and susceptibility of Helicobacter pylori to medicinal plant extracts